{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:35:40Z","timestamp":1761896140628,"version":"build-2065373602"},"reference-count":71,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.canrad.2015.05.016","type":"journal-article","created":{"date-parts":[[2015,8,13]],"date-time":"2015-08-13T11:59:34Z","timestamp":1439467174000},"page":"582-589","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Suivi apr\u00e8s radioth\u00e9rapie des cancers de prostate\u00a0: \u00e9valuation et prise en charge de la toxicit\u00e9 et de la r\u00e9cidive"],"prefix":"10.1016","volume":"19","author":[{"given":"G.","family":"Dupic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Hennequin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2015.05.016_bib0360","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.ejca.2013.09.002","article-title":"Recent trends in incidence of five common cancers in 26\u00a0European countries since 1988: analysis of the European Cancer Observatory","volume":"51","author":"Arnold","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.canrad.2015.05.016_bib0365","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1470-2045(13)70546-1","article-title":"Cancer survival in Europe 1999\u20132007\u00a0by country and age: results of EUROCARE\u20135-a population-based study","volume":"15","author":"De Angelis","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2015.05.016_bib0370","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.canrad.2011.07.242","article-title":"Quel programme de surveillance apr\u00e8s radioth\u00e9rapie\u00a0?","volume":"15","author":"Dewas","year":"2011","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2015.05.016_bib0375","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.eururo.2013.09.046","article-title":"EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent\u2013Update 2013","volume":"65","author":"Heidenreich","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.canrad.2015.05.016_bib0380","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.canrad.2011.05.005","article-title":"Suivi apr\u00e8s la radioth\u00e9rapie des cancers de la prostate\u00a0: bases scientifiques, rapport co\u00fbt\u2013b\u00e9n\u00e9fice","volume":"15","author":"Supiot","year":"2011","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2015.05.016_bib0385","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1470-2045(13)70606-5","article-title":"Incidence of complications other than urinary incontinence or erectile dysfunction after radical prostatectomy or radiotherapy for prostate cancer: a population-based cohort study","volume":"15","author":"Nam","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2015.05.016_bib0390","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ijrobp.2007.11.044","article-title":"Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer","volume":"70","author":"Zelefsky","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2015.05.016_bib0395","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijrobp.2009.07.1742","article-title":"Correlation between acute and late toxicity in 973\u00a0prostate cancer patients treated with three-dimensional conformal external beam radiotherapy","volume":"78","author":"Jereczek-Fossa","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2015.05.016_bib0400","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S1470-2045(14)70482-6","article-title":"Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3\u00a0trial","volume":"16","author":"Aluwini","year":"2015","journal-title":"Lancet Oncol"},{"year":"2010","series-title":"Common Toxicity Criteria for adverse events (CTCAE) Version 4.03","author":"Anon","key":"10.1016\/j.canrad.2015.05.016_bib0405"},{"key":"10.1016\/j.canrad.2015.05.016_bib0410","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.canrad.2012.05.014","article-title":"Toxicit\u00e9 rectale de la radioth\u00e9rapie\u00a0: signes cliniques, physiopathologie et prise en charge","volume":"16","author":"Kintzinger","year":"2012","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2015.05.016_bib0415","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.radonc.2012.05.007","article-title":"Late gastrointestinal and urogenital side-effects after radiotherapy\u2013Incidence and prevalence. Subgroup-analysis within the prospective Austrian\u2013German phase II multicenter trial for localized prostate cancer","volume":"104","author":"Schmid","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2015.05.016_bib0420","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.radonc.2007.06.013","article-title":"Late radiotherapy-induced lower intestinal toxicity (RILIT) of intensity-modulated radiotherapy for prostate cancer: the need for adapting toxicity scales and the appearance of the sigmoid colon as co-responsible organ for lower intestinal toxicity","volume":"84","author":"Fonteyne","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2015.05.016_bib0425","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ijrobp.2008.04.063","article-title":"Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer","volume":"73","author":"Al-Mamgani","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2015.05.016_bib0430","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.radonc.2013.03.022","article-title":"Prostate stereotactic ablative body radiotherapy using a standard linear accelerator: toxicity, biochemical, and pathological outcomes","volume":"107","author":"Loblaw","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2015.05.016_bib0435","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.ijrobp.2009.05.052","article-title":"Late gastrointestinal toxicity after dose-escalated conformal radiotherapy for early prostate cancer: results from the UK Medical Research Council RT01\u00a0trial (ISRCTN47772397)","volume":"77","author":"Syndikus","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2015.05.016_bib0440","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/j.ijrobp.2011.12.046","article-title":"Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy","volume":"83","author":"Ippolito","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2015.05.016_bib0445","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.canrad.2010.07.225","article-title":"Radioth\u00e9rapie prostatique\u00a0: pr\u00e9diction de la toxicit\u00e9 tardive \u00e0 partir des donn\u00e9es dosim\u00e9triques","volume":"14","author":"de Crevoisier","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2015.05.016_bib0450","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.radonc.2014.11.025","article-title":"Effects of a dietary intervention on gastrointestinal symptoms after prostate cancer radiotherapy: long-term results from a randomized controlled trial","volume":"113","author":"Pettersson","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2015.05.016_bib0455","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.gtc.2013.08.004","article-title":"Management of radiation proctitis","volume":"42","author":"Sarin","year":"2013","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.canrad.2015.05.016_bib0460","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ijrobp.2011.12.056","article-title":"Hyperbaric oxygen therapy for radiation-induced cystitis and proctitis","volume":"84","author":"Oliai","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2015.05.016_bib0465","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.clon.2007.07.008","article-title":"Treatment of radiation proctitis","volume":"19","author":"Leiper","year":"2007","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.canrad.2015.05.016_bib0470","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.canrad.2010.02.007","article-title":"Dose de tol\u00e9rance \u00e0 l\u2019irradiation des tissus sains\u00a0: la vessie","volume":"14","author":"Pointreau","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2015.05.016_bib0475","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.ijrobp.2008.09.032","article-title":"Hypofractionated intensity-modulated radiotherapy for carcinoma of the prostate: analysis of toxicity","volume":"74","author":"Coote","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2015.05.016_bib0480","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijrobp.2010.09.027","article-title":"Clinical factors predicting late severe urinary toxicity after postoperative radiotherapy for prostate carcinoma: a single-institute analysis of 742\u00a0patients","volume":"82","author":"Cozzarini","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2015.05.016_bib0485","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.purol.2012.12.006","article-title":"Curieth\u00e9rapie exclusive du cancer de la prostate par implants permanents\u00a0: indications et r\u00e9sultats. Revue du CC-Afu","volume":"23","author":"Hennequin","year":"2013","journal-title":"Prog Urol"},{"key":"10.1016\/j.canrad.2015.05.016_bib0490","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.radonc.2014.02.006","article-title":"Relationships between bladder dose\u2013volume\/surface histograms and acute urinary toxicity after radiotherapy for prostate cancer","volume":"111","author":"Carillo","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2015.05.016_bib0495","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.radonc.2010.08.002","article-title":"The relationship between external beam radiotherapy dose and chronic urinary dysfunction\u2013A methodological critique","volume":"97","author":"Rosewall","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2015.05.016_bib0500","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.radonc.2012.09.020","article-title":"The effect of radiation technique and bladder filling on the acute toxicity of pelvic radiotherapy for localized high risk prostate cancer","volume":"105","author":"Jain","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2015.05.016_bib0505","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.juro.2014.06.030","article-title":"Cystectomy for refractory hemorrhagic cystitis: contemporary etiology, presentation and outcomes","volume":"192","author":"Linder","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.canrad.2015.05.016_bib0510","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/S1166-7087(12)70039-8","article-title":"Sexualit\u00e9 et cancer de la prostate","volume":"22","author":"Colson","year":"2012","journal-title":"Prog Urol"},{"key":"10.1016\/j.canrad.2015.05.016_bib0515","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0360-3016(02)03030-4","article-title":"Meta-analysis of rates of erectile function after treatment of localized prostate carcinoma","volume":"54","author":"Robinson","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2015.05.016_bib0520","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.radonc.2014.04.017","article-title":"Long-term erectile function following permanent seed brachytherapy treatment for localized prostate cancer","volume":"112","author":"Ong","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2015.05.016_bib0525","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.radonc.2007.07.018","article-title":"Erectile dysfunction after radiotherapy for prostate cancer and radiation dose to the penile structures: a critical review","volume":"84","author":"Van der Wielen","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2015.05.016_bib0530","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.canrad.2010.07.223","article-title":"Dysfonctions sexuelles apr\u00e8s irradiation pour cancer de la prostate","volume":"14","author":"Droupy","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2015.05.016_bib0535","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/S0360-3016(01)01767-9","article-title":"Sildenafil citrate (Viagra) and erectile dysfunction following external beam radiotherapy for prostate cancer: a randomized, double-blind, placebo-controlled, cross-over study","volume":"51","author":"Incrocci","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2015.05.016_bib0540","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.purol.2013.09.017","article-title":"Les m\u00e9dicaments de la m\u00e9decine sexuelle","volume":"23","author":"Karsenty","year":"2013","journal-title":"Prog Urol"},{"key":"10.1016\/j.canrad.2015.05.016_bib0545","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.radonc.2013.12.012","article-title":"Second primary cancers after radiation for prostate cancer: a systematic review of the clinical data and impact of treatment technique","volume":"110","author":"Murray","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2015.05.016_bib0550","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.radonc.2013.06.039","article-title":"Quality of life among prostate cancer patients: a prospective longitudinal population-based study","volume":"108","author":"Schaake","year":"2013","journal-title":"Radiother Oncol"},{"year":"2015","series-title":"FRAX\u00ae Outil d\u2019\u00e9valuation des risques de fractures [outil de calcul sur Internet]","author":"Anon","key":"10.1016\/j.canrad.2015.05.016_bib0555"},{"key":"10.1016\/j.canrad.2015.05.016_bib0560","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/S1166-7087(13)70048-4","article-title":"Recommandations en onco-urologie 2013\u00a0du CCAFU\u00a0: cancer de la prostate","volume":"23","author":"Salomon","year":"2013","journal-title":"Prog Urol"},{"key":"10.1016\/j.canrad.2015.05.016_bib0565","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.radonc.2008.10.004","article-title":"PSA response signatures\u2013a powerful new prognostic indicator after radiation for prostate cancer?","volume":"90","author":"Denham","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2015.05.016_bib0570","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2015.05.016_bib0575","first-page":"1035","article-title":"Consensus statement: guidelines for PSA following radiation therapy","volume":"37","author":"American Society for Therapeutic Radiology, Oncology Consensus Panel","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2015.05.016_bib0580","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1200\/JCO.2005.04.0756","article-title":"Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition","volume":"24","author":"Stephenson","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2015.05.016_bib0585","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/01.ju.0000152556.53602.64","article-title":"Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysis","volume":"173","author":"Horwitz","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.canrad.2015.05.016_bib0590","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0022-5347(01)66713-2","article-title":"The incidence of prostate cancer progression with undetectable serum prostate specific antigen in a series of 394\u00a0radical prostatectomies","volume":"154","author":"Oefelein","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.canrad.2015.05.016_bib0595","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.eururo.2014.09.028","article-title":"The natural history and predictors of outcome following biochemical relapse in the dose escalation era for prostate cancer patients undergoing definitive external beam radiotherapy","volume":"67","author":"Zumsteg","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.canrad.2015.05.016_bib0600","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.clon.2004.10.009","article-title":"The utility of digital rectal examination after radical radiotherapy for prostate cancer","volume":"17","author":"Doneux","year":"2005","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.canrad.2015.05.016_bib0605","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.eururo.2005.07.006","article-title":"Digital rectal examination is no longer necessary in the routine follow-up of men with undetectable prostate specific antigen after radical prostatectomy: the implications for follow-up","volume":"48","author":"Chaplin","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.canrad.2015.05.016_bib0610","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0090-4295(02)02411-1","article-title":"Limited value of bone scintigraphy and computed tomography in assessing biochemical failure after radical prostatectomy","volume":"61","author":"Kane","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.canrad.2015.05.016_bib0615","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.purol.2014.12.002","article-title":"Imagerie post-th\u00e9rapeutique du cancer de la prostate","volume":"25","author":"Renard-Penna","year":"2015","journal-title":"Prog Urol"},{"key":"10.1016\/j.canrad.2015.05.016_bib0620","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.diii.2012.01.012","article-title":"Imaging techniques for local recurrence of prostate cancer: for whom, why and how?","volume":"93","author":"Rouvi\u00e8re","year":"2012","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.canrad.2015.05.016_bib0625","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.clon.2009.10.015","article-title":"A systematic review of the role of imaging before salvage radiotherapy for post-prostatectomy biochemical recurrence","volume":"22","author":"Beresford","year":"2010","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.canrad.2015.05.016_bib0630","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.purol.2015.01.018","article-title":"R\u00e9cidive biochimique apr\u00e8s traitement curatif d\u2019un ad\u00e9nocarcinome prostatique localis\u00e9\u00a0: int\u00e9r\u00eat de la TEP \u00e0 la choline dans l\u2019\u00e9valuation de la r\u00e9cidive locale","volume":"25","author":"Poncet","year":"2015","journal-title":"Prog Urol"},{"key":"10.1016\/j.canrad.2015.05.016_bib0635","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00345-012-0908-z","article-title":"Impact of total PSA, PSA doubling time and PSA velocity on detection rates of (11C)-choline positron emission tomography in recurrent prostate cancer","volume":"31","author":"Rybalov","year":"2013","journal-title":"World J Urol"},{"key":"10.1016\/j.canrad.2015.05.016_bib0640","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.eururo.2013.05.025","article-title":"Management of biochemical recurrence after primary treatment of prostate cancer: a systematic review of the literature","volume":"64","author":"Punnen","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.canrad.2015.05.016_bib0645","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1002\/cncr.26631","article-title":"Whole-gland salvage high-intensity focused ultrasound therapy for localized prostate cancer recurrence after external beam radiation therapy","volume":"118","author":"Uddin Ahmed","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2015.05.016_bib0650","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.purol.2013.08.314","article-title":"Prostatectomie radicale de sauvetage apr\u00e8s \u00e9chec de curieth\u00e9rapie\u00a0: \u00e9tude pr\u00e9liminaire","volume":"24","author":"Saeedi","year":"2014","journal-title":"Prog Urol"},{"key":"10.1016\/j.canrad.2015.05.016_bib0655","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.purol.2009.11.006","article-title":"Prostatectomie de rattrapage apr\u00e8s \u00e9chec de radioth\u00e9rapie externe pour cancer de la prostate localis\u00e9\u00a0: enqu\u00eate de pratique, indications, morbidit\u00e9 et r\u00e9sultats. Travail du CCAFU sous-comit\u00e9 prostate","volume":"20","author":"Paparel","year":"2010","journal-title":"Prog Urol"},{"key":"10.1016\/j.canrad.2015.05.016_bib0660","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.canrad.2014.07.103","article-title":"Curieth\u00e9rapie de rattrapage focale de haut d\u00e9bit de dose apr\u00e8s une irradiation premi\u00e8re d\u2019un cancer localis\u00e9 de la prostate","volume":"18","author":"Didas","year":"2014","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2015.05.016_bib0665","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.ijrobp.2009.06.061","article-title":"Long-term outcome and toxicity of salvage brachytherapy for local failure after initial radiotherapy for prostate cancer","volume":"77","author":"Burri","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2015.05.016_bib0670","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.canrad.2014.04.002","article-title":"Cryoth\u00e9rapie de rattrapage apr\u00e8s radioth\u00e9rapie prostatique\u00a0: principes, indications, s\u00e9lection des patients, r\u00e9sultats oncologiques et morbidit\u00e9","volume":"18","author":"H\u00e9tet","year":"2014","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2015.05.016_bib0675","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.purol.2014.08.235","article-title":"Traitements de rattrapage par HIFU apr\u00e8s radioth\u00e9rapie premi\u00e8re et par radioth\u00e9rapie apr\u00e8s HIFU premi\u00e8re dans la r\u00e9cidive locale du cancer de prostate\u00a0: analyse r\u00e9trospective de la toxicit\u00e9","volume":"24","author":"Lee","year":"2014","journal-title":"Prog Urol"},{"key":"10.1016\/j.canrad.2015.05.016_bib0680","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.crad.2012.12.010","article-title":"Salvage high-intensity focused ultrasound ablation for prostate cancer local recurrence after external-beam radiation therapy: prognostic value of prostate MRI","volume":"68","author":"Rouvi\u00e8re","year":"2013","journal-title":"Clin Radiol"},{"key":"10.1016\/j.canrad.2015.05.016_bib0685","first-page":"800","article-title":"Traitement focal de rattrapage des r\u00e9cidives de cancer de prostate apr\u00e8s radioth\u00e9rapie par HIFU","volume":"22","author":"Crouzet","year":"2012","journal-title":"Prog Urol"},{"key":"10.1016\/j.canrad.2015.05.016_bib0690","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.purol.2010.07.018","article-title":"Th\u00e9rapie photodynamique et cancer de la prostate","volume":"21","author":"Colin","year":"2011","journal-title":"Prog Urol"},{"key":"10.1016\/j.canrad.2015.05.016_bib0695","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.canrad.2014.07.153","article-title":"Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how?","volume":"18","author":"Cr\u00e9hange","year":"2014","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2015.05.016_bib0700","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.canrad.2013.07.048","article-title":"RCMI des r\u00e9cidives ganglionnaires pelviennes et\/ou lombo-aortiques apr\u00e8s traitement local du cancer prostatique","volume":"17","author":"Jouin","year":"2013","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2015.05.016_bib0705","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.ijrobp.2010.11.031","article-title":"Robotic image-guided stereotactic radiotherapy, for isolated recurrent primary, lymph node or metastatic prostate cancer","volume":"82","author":"Jereczek-Fossa","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2015.05.016_bib0355","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.canrad.2014.06.007","article-title":"Medical treatment for biochemical relapse after radiotherapy","volume":"18","author":"Quero","year":"2014","journal-title":"Cancer Radiother"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S127832181500133X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S127832181500133X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:24:52Z","timestamp":1761135892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S127832181500133X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":71,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S127832181500133X"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2015.05.016","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suivi apr\u00e8s radioth\u00e9rapie des cancers de prostate\u00a0: \u00e9valuation et prise en charge de la toxicit\u00e9 et de la r\u00e9cidive","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2015.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}